title: Topical use of cidofovir induced acute renal failure.
abstract: BACKGROUND
  Cidofovir has antiviral activity against a wide spectrum of DNA viruses. Several small studies have focused on the efficacy of topical cidofovir in various viral-induced diseases. We report a systemic complication of such therapy.
  
  
  METHODS
  A bone marrow transplant recipient with chronic renal failure developed genital condylomas resistant to standard therapy. After topical cidofovir application (1% once daily for 5 days, then 4% for 12 days), the lesions improved while local erosions appeared. Acute renal failure with features of tubular acidosis occurred at day 19. Spontaneous recovery was observed after cidofovir withdrawal.
  
  
  CONCLUSIONS
  We describe for the first time acute renal failure after topical cidofovir in an immunosuppressed patient with prior renal insufficiency. This method of administration should be avoided on abraded skin and should be carefully monitored.
authors.affiliation: Department of Dermatology, Hôpital Saint-Louis, Paris, France.
authors.forename: B
authors.initials: B
authors.lastname: Bienvenu
authors.forename: F
authors.initials: F
authors.lastname: Martinez
authors.forename: A
authors.initials: A
authors.lastname: Devergie
authors.forename: M
authors.initials: M
authors.lastname: Rybojad
authors.forename: J
authors.initials: J
authors.lastname: Rivet
authors.forename: P
authors.initials: P
authors.lastname: Bellenger
authors.forename: P
authors.initials: P
authors.lastname: Morel
authors.forename: E
authors.initials: E
authors.lastname: Gluckman
authors.forename: C
authors.initials: C
authors.lastname: Lebbé
mesh_terms: D058186:Acute Kidney Injury / Q000139:chemically induced*; D000287:Administration, Topical; D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects*; D016026:Bone Marrow Transplantation; D000077404:Cidofovir; D003218:Condylomata Acuminata / Q000188:drug therapy*; D003596:Cytosine / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000601:surgery*; D008297:Male; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000008:administration & dosage / Q000009:adverse effects*; D011183:Postoperative Complications / Q000821:virology; D017211:Treatment Failure; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D003596:Cytosine; D000077404:Cidofovir